Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.735
Delayed Data
As of Mar 27
 +0.0128 / +1.77%
Today’s Change
0.65
Today|||52-Week Range
1.29
+5.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-11.3M-6.2M-9.5M--
 
 
 
 
Depreciation45.1K42.4K37.1K--
 
 
 
 
Total Other Cash Flow-4.1M-246.1K1.7M--
 
 
 
 
Funds From Operations-15.4M-6.4M-7.8M--
 
 
 
 
Funds From/For Other Operating Expenses116.5K189.2K181.8K--
 
 
 
 
Net Cash Flow - Operating Activities-15.5M-6.6M-8.0M-11.1M
 
 
 
 
 
 
InvestingIncrease In Investments-8.0M0.000.00--
 
 
Decrease In Investments8.5M1.9M0.00--
 
 
 
Capital Expenditures-16.0K0.00-50.1K--
 
 
 
Other Investing - Uses-1.0M0.000.00--
 
 
Other Investing - Sources0.00340.0K895.7K--
 
 
 
Net Cash Flow Investing-545.9K2.2M845.5K--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale13.6M7.1M12.3M24.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00926.0K0.00--
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing13.6M8.1M12.3M24.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-2.5M3.6M5.2M13.7M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account